140 related articles for article (PubMed ID: 36938936)
1. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase.
Bosland MC; Vega K; Horton L; Schlicht MJ
Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936
[TBL] [Abstract][Full Text] [Related]
2. Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.
Ozten N; Vega K; Liehr J; Huang X; Horton L; Cavalieri EL; Rogan EG; Bosland MC
Horm Cancer; 2019 Jun; 10(2-3):77-88. PubMed ID: 30877616
[TBL] [Abstract][Full Text] [Related]
3. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
4. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho SM; Yu M
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
[TBL] [Abstract][Full Text] [Related]
5. Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.
Ozten N; Horton L; Lasano S; Bosland MC
Cancer Prev Res (Phila); 2010 Mar; 3(3):371-80. PubMed ID: 20179302
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
Lane KE; Ricci MJ; Ho SM
Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
[TBL] [Abstract][Full Text] [Related]
7. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis.
Bosland MC
Ann N Y Acad Sci; 2006 Nov; 1089():168-76. PubMed ID: 17261765
[TBL] [Abstract][Full Text] [Related]
8. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
Bosland MC; Ford H; Horton L
Carcinogenesis; 1995 Jun; 16(6):1311-7. PubMed ID: 7788848
[TBL] [Abstract][Full Text] [Related]
9. A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.
Bosland MC
Cancer Lett; 2013 Jun; 334(1):28-33. PubMed ID: 22939996
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progestin receptors and aromatase activity in rhesus monkey prostate.
West NB; Roselli CE; Resko JA; Greene GL; Brenner RM
Endocrinology; 1988 Nov; 123(5):2312-22. PubMed ID: 3262505
[TBL] [Abstract][Full Text] [Related]
11. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
Miao L; Jiao C; Shao R; Qi Y; Fan G; Li X; Wang Y; Zhu Y; Zhang J; Gao X
Toxicol Appl Pharmacol; 2019 Oct; 381():114637. PubMed ID: 31238046
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
13. Detection of estradiol in rat brain tissues: Contribution of local versus systemic production.
Li J; Gibbs RB
Psychoneuroendocrinology; 2019 Apr; 102():84-94. PubMed ID: 30529907
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
Ofner P; Bosland MC; Vena RL
Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
[TBL] [Abstract][Full Text] [Related]
15. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
Ellem SJ; Risbridger GP
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
[TBL] [Abstract][Full Text] [Related]
16. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
17. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
18. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
[TBL] [Abstract][Full Text] [Related]
19. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
Han X; Liehr JG; Bosland MC
Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
[TBL] [Abstract][Full Text] [Related]
20. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.
Ricke WA; McPherson SJ; Bianco JJ; Cunha GR; Wang Y; Risbridger GP
FASEB J; 2008 May; 22(5):1512-20. PubMed ID: 18055862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
